ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,000 | -6.7% | 10,424 | 0.0% | 0.01% | -18.2% |
| Q1 2018 | $15,000 | -34.8% | 10,424 | 0.0% | 0.01% | -31.2% |
| Q4 2017 | $23,000 | -88.2% | 10,424 | -81.8% | 0.02% | -88.1% |
| Q3 2017 | $195,000 | +16.1% | 57,424 | +21.1% | 0.13% | +15.5% |
| Q2 2017 | $168,000 | +20.9% | 47,424 | +15.6% | 0.12% | +20.8% |
| Q1 2017 | $139,000 | +152.7% | 41,008 | +241.5% | 0.10% | +152.6% |
| Q4 2016 | $55,000 | – | 12,008 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |